This is not how I would have preferred to get rich off of NNVC. But each passing hour seems to be drawing us closer to a global pandemic and a potential world wide health catastrophe. Look at the time stamp of this Press Release by Ludlow BioVentures. Something wicked this way comes.
Nanoviricides, Inc. (NNVC) Research Opinion
Last Updated: April 24, 2009 - 9:17pm EST
NEW YORK--Ludlow BioVentures upgrades its research rating on Nanoviricides, Inc. (OTC: NNVC), a development stage company that is creating special purpose nanomaterials for viral therapy, maintains A- rating, and near-term price target of $2.50 per share based on potential 'swine flu' pandemic. Interview pending.
Recent announcement of an outbreak of a new strain of the H1N1 swine Influenza should put viral research companies, such as NanoViricieds (NNVC), in play this coming week. NanoViricieds utilizes creative and unique nanomaterials for targeting and destroying viruses. The company's nanoviricide(TM) drug candidates are designed to specifically attack enveloped virus particles and dismantle them, as opposed to vaccines which work to prevent the delivery of the virus payload. This unique approach makes NNVC a interesting play in the field of viral therapy, and may hold some very promising cures to a number of viral infections.
To this effect, Ludlow BioVentures is maintaining NNVC rating of A-, but raising its near-term price target to $2.50 to $3.00, with longer-range price target of $5.00 per share.
Pending Investor Interview
Ludlow BioVentures has been in contact with Dr. Eugene Seymour, the President and CEO of NanoViricieds, to discuss this recent swine flu outbreak, and CDC reaction. We anticipate conducting an investor call with the company sometime over the weekend to discuss his take on this breaking news event, and how NNVC could be a strategic player in preventing current and future viral pandemics. Register below for Updates
Officials: 8 NYC Students Probably Have Swine Flu
Swine flu could infect U.S. trade and travel
Swine Flu May Be Named Event of ‘International Concern’ by WHO